The body’s protective immune system holds the key to diagnosing, treating and vaccinating against coronavirus. Science Director, Roger Highfield, focuses on antibodies.

The development of COVID-19 treatments, tests, drugs and vaccines will be accelerated by molecular understanding of the COVID-19 virus. Roger Highfield, Science Director, looks at what is happening in Britain’s most prestigious molecular biology laboratory.

Roger Highfield, Science Director, on why the fate of the nation rests on R, the ‘reproduction number’, and a novel ‘stringency index’ that compares the pandemic responses of 160 nations.

Roger Highfield, Science Director, discusses how digital technologies can curb COVID-19 with Hannah Fry, who conducted a prescient simulation of a UK outbreak, and Dr Alice Tan of MizMedi Women’s Hospital, who explains why South Korea’s death toll is relatively low.

Curator Katie Dabin explores how 1960s research into the common cold helped reveal the first coronavirus.

The first encouraging news in the global hunt for treatments to curb the pandemic was reported last week. Roger Highfield, Science Director, describes the race to cure COVID-19.

Roger Highfield, Science Director, talks to Kari Stefansson, whose genetic sequencing project has revealed how the UK infected Iceland, that children don’t seem to infect parents, and how to control COVID-19.

Roger Highfield, Science Director, outlines the science of lockdowns and how to end the pandemic.

One month on since the closure of our museums due to the coronavirus pandemic, Chief Executive Sir Ian Blatchford reflects on the challenges facing us all and how the Group has adapted to its new (although temporary) virtual reality.

Roger Highfield, Science Director, talks to Ajit Lalvani, who recently recovered from a serious COVID-19 infection and is now undertaking a major pandemic study